MEDX Among Health Care ETFs
End-of-day Nov 20, 2026 · 31 Health care ETFs by 3Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.3% | −5.7% | −3.3% | −4.2% | +8.0% | +10.7% | +39.3% | — | — | +25.9% |
| Peer average | −1.3% | −6.4% | −4.5% | −5.9% | +13.4% | +17.5% | +58.2% | +19.5% | +146.1% | — |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$212 of every $1,000 in MEDX is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYEli Lilly | Healthcare | 21.22% | $2,122.49 | 2,654 | $3.6M |
| 2 | ABBVAbbVie | Healthcare | 10.18% | $1,018.38 | 6,068 | $1.7M |
| 3 | —US Bank Mmda - Usbgfs 7 06/01/2031 | — | 8.17% | $816.93 | 1.4M | $1.4M |
| 4 | NVSNovartis AG | Healthcare | 6.79% | $678.65 | 7,582 | $1.1M |
| 5 | JNJJohnson & Johnson | Healthcare | 6.01% | $600.54 | 3,798 | $1.0M |
| 6 | ALKSAlkermes | Healthcare | 4.97% | $497.43 | 18K | $840K |
| 7 | AMGNAmgen | Healthcare | 4.81% | $481.37 | 1,864 | $813K |
| 8 | AZNAstraZeneca | Healthcare | 4.71% | $470.64 | 4,533 | $795K |
| 9 | MRKMerck | Healthcare | 4.17% | $417.26 | 5,308 | $705K |
| 10 | BMYBristol-Myers Squibb | Healthcare | 4.12% | $412.17 | 12K | $696K |
| 11 | BIIBBiogen | Healthcare | 3.60% | $360.43 | 2,464 | $609K |
| 12 | PFEPfizer | Healthcare | 3.34% | $333.71 | 20K | $564K |
| 13 | REGNRegeneron Pharmaceuticals | Healthcare | 3.11% | $311.20 | 570 | $526K |
| 14 | GSKGSK | Healthcare | 2.52% | $251.91 | 8,900 | $426K |
| 15 | CRSPCRISPR Therapeutics AG | Healthcare | 1.92% | $192.22 | 8,342 | $325K |
of the $110B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | Eli Lilly & | 21.22% |
| 2 | ABBV | AbbVie | 10.18% |
| 3 | NVS | Novartis AG | 6.79% |
| 4 | JNJ | Johnson & Johnson | 6.01% |
| 5 | ALKS | Alkermes | 4.97% |
| 6 | AMGN | Amgen | 4.81% |
| 7 | AZN | AstraZeneca | 4.71% |
| 8 | MRK | Merck & | 4.17% |
| 9 | BMY | Bristol-Myers Squibb | 4.12% |
| 10 | BIIB | Biogen | 3.60% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 23, 2025 | Dec 24, 2025 | $0.41 |
| Dec 24, 2024 | Dec 26, 2024 | $0.51 |
| Dec 27, 2023 | Dec 29, 2023 | $1.64 |